Dyne Therapeutics, Inc. Common Stock
Here’s whether Dyne Therapeutics, Inc. Common Stock (DYN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+6.11% over 10 days); RSI 60 — healthy momentum range; strong 1-year return of +164.5%; 3-month momentum positive (+33.8%); rising volume confirms the move (1.18x 30d avg). Currently 2.2% off its 52-week high. Score: +8/7.
DYN is in a confirmed uptrend, trading above both its 50-day ($20.26) and 200-day ($18.83) moving averages. An RSI of 60.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +164.5% compares to +16.5% for SPY (beat the market by 148.0%).